FIELD: medicine. SUBSTANCE: method involves introducing collagen powder into the pleural cavity in the amount of 1.0-1.5 g as suspension in physiological sodium chloride solution. 10- 15 ml of 2% Lidocaine solution is additionally added to the suspension for making pleural cavity anesthesia and preventing pain syndrome when contacting to collagen particles. EFFECT: enhanced effectiveness of pleurodesis; avoided pain syndrome and temperature response; prevented recidivation. 3 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING EXUDATIVE PLEURISY | 2017 |
|
RU2666401C1 |
| METHOD OF TREATMENT OF PANCREATOGENIC EXUDATIVE PLEURISY | 2017 |
|
RU2657621C1 |
| METHOD OF PLEURODESIS WITH SILVER-ALLOYED TITANIUM NICKELIDE POWDER | 2023 |
|
RU2810367C1 |
| METHOD OF SECONDARY RECURRING TRANSSUDATE PLEURITIS TREATMENT | 2008 |
|
RU2365346C1 |
| INTEGRATED TREATMENT OF MALIGNANT TUMOUR PLEURA INVOLVEMENT ACCOMPANIED WITH EXUDATIVE PLEURISY | 2008 |
|
RU2358775C1 |
| TREATMENT METHOD OF EXUDATIVE PLEURISY | 2019 |
|
RU2704569C1 |
| METHOD FOR INTRAOPERATIVE PREVENTION OF LONG-TERM AIR LEAKAGE IN PATIENTS WITH LUNG CANCER DURING ORGAN-PRESERVING ANATOMICAL RESECTIONS | 2022 |
|
RU2789983C1 |
| METHOD OF PLEURODES AT SPONTANEOUS PNEUMOTHORAX | 1991 |
|
RU2008904C1 |
| METHOD FOR PHOTODYNAMIC THERAPY OF PATIENTS WITH METASTATIC TUMOURAL PLEURITIS | 2013 |
|
RU2514107C1 |
| METHOD FOR DIAGNOSIS OF ENDOGENOUS INTOXICATION SYNDROME | 2002 |
|
RU2234095C1 |
